Patient Blood Management for Massive Obstetric Hemorrhage
ROTEM Guided and Hemostatic Drugs Algorithms vs Standard Coagulation Test and Hemocomponent for Massive Obstetric Hemorrhage
Sponsor: Angel Augusto Perez Calatayud
This NA trial investigates Fibrinogen; Deficiency, Acquired and Fibrinogenolysis; Hemorrhage and is currently completed. Angel Augusto Perez Calatayud leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Terminated → Recruiting
▶ Show 3 earlier versions
-
Feb 2020 — Apr 2020 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Aug 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jan 2019 — Aug 2019 [monthly]
Recruiting NA
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Angel Augusto Perez Calatayud
- Grupo Mexicano para el Estudio de la Medicina Intensiva
For direct contact, visit the study record on ClinicalTrials.gov .